Biocept Inc reports results for the quarter ended in June - Earnings Summary

Biocept

16/08/2021 22:57

* Biocept Inc  BIOC.OQ  reported a quarterly adjusted loss of 14
cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 16 cents per
share.
* Revenue rose 1,213.1% to $12.05 million from a year ago; 
analysts expected $9.74 million. 
* Biocept Inc's reported EPS for the quarter was a loss of 14
cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Biocept Inc shares had fallen by 4.5% this quarter and
lost 9.9% so far this year.
* The company reported a quarterly loss of $1.83 million.
* Wall Street's median 12-month price target for Biocept Inc is
$12.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 09:57 p.m.  ​All
figures in US dollars unless otherwise stated